Life Sciences & Healthcare Newsletter | Edition 9 – 2024

October 31, 2024

See in this edition of Life Sciences & Healthcare Newsletter:

 

  • Supreme Court Reaches Judgement on the State's Obligation to Provide Medications Not Included in SUS List

  • ANVISA Opens New Public Inquiry on the Execution of Agreements for the Regularization of Medications

  • ANS Launches Public Inquiry on Regulatory Sandbox

  • ANVISA Consolidates Rules on Ownership/Responsibility Transfers Due to Corporate or Commercial Transactions

  • ANVISA Consolidates Rules Related to the Regulation of Cosmetic Products

  • ANVISA Also Consolidates Rules Applicable to Pharmaceutical Equivalence Centers

  • ANVISA Consolidates Rules Related to Activities in Health Services
     

To check out the full content, please click here.

Publication produced by our Life Sciences & Healthcare